Phase 2 dose-ranging study to evaluate the efficacy and safety of liposomal irinotecan (LY01610) as a second-line treatment for patients with relapsed small cell lung cancer

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2024-09-01
DOI
https://doi.org/10.1016/j.eclinm.2024.102791
Citations
4
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
1.13

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase 2 dose-ranging study to evaluate the efficacy and safety of liposomal irinotecan (LY01610) as a second-line treatment for patients with relapsed small cell lung cancer

Yueyin Pan, Tianyi Gan, Puyuan Xing, Jia Zeng et al.
4 citations
EClinicalMedicine
Lung Cancer Research Studies
1.13
article

Phase 2 dose-ranging study to evaluate the efficacy and safety of liposomal irinotecan (LY01610) as a second-line treatment for patients with relapsed small cell lung cancer

Yueyin Pan, Tianyi Gan, Puyuan Xing, Jia Zeng, Minghong Bi, Shan‐Bing Wang, Yuankai Shi, Xiao Ke, Lei Zhang, Yingchun Wang, Biyong Ren, Xicheng Wang, Guang Cheng, Pu Wang, Weidong Li, Jun Guo, Emei Gao, Yong Liu
article en
4 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 75
Hebei Medical University (CN), University of Science and Technology of China (CN), China Pharmaceutical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Medical Products Administration (CN), Shantou University (CN), Luye Pharma (Germany) (DE), First Affiliated Hospital of Guangzhou Medical University (CN), Xingtai People's Hospital (CN), First Affiliated Hospital of Guangdong Pharmaceutical University (CN), Second Affiliated Hospital of Shantou University Medical College (CN), Chongqing Three Gorges Central Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Xuzhou Central Hospital (CN), Luye Pharma (China) (CN), First Affiliated Hospital of Bengbu Medical College (CN), Guangzhou Medical University Cancer Hospital (CN), Second People’s Hospital of Yibin (CN), Chongqing Three Gorges University (CN), Chongqing Medical University (CN), Guangzhou Medical University (CN)
Tongji University, Chinese Academy of Medical Sciences, Peking Union Medical College
Good health and well-being
Openalex Percentile: Top 18%
Lung Cancer Research Studies
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.